Rare diseases
Investigational molecules
Locations
279 conditions with trials, the busiest first
686 trials across Europe, recruiting first
Study on ITPP and Sodium Chloride for Patients with COVID-19 and Other Lung Infections Facing Breathing Problems
PolandDrug interaction study of leniolisib with a drug combination in healthy volunteers for Activated PI3K Delta Syndrome
GermanyRelative Bioavailability of Sisunatovir Capsules vs Tablets in Fasted and Fed Conditions in Healthy Adults with Respiratory Syncytial Virus
BelgiumSafety and Immunogenicity of SARS-COV-2 VIRUS, VARIANT LP.8.1, SPIKE PROTEIN, RECEPTOR BINDING DOMAIN FUSION HOMODIMER Vaccine in Adults with COVID-19
SpainEvaluating the effect of recombinant varicella zoster virus glycoprotein E vaccine on heart problems and dementia in adults aged 65 years or older with herpes zoster
DenmarkA study of the effects of nirmatrelvir, ritonavir, and rosuvastatin in healthy adult participants
BelgiumMultiple Ascending Dose Safety, Tolerability and Pharmacokinetics of MK-7602 in Healthy Volunteers for Malaria
BelgiumSafety, Tolerability and Antiretroviral Activity of a Single Oral Dose of MK-8527 in ART‑Naïve Adults with HIV‑1
RomaniaSafety, Tolerability, and Pharmacokinetics of MK-3508 in Healthy Adults for Treatment of Respiratory Syncytial Virus Infection
BelgiumA study to evaluate the taste of sisunatovir and denatonium benzoate in healthy adults for the treatment of respiratory syncytial virus (RSV)
BelgiumBioequivalence Study of Amoxicillin/Clavulanic Acid Oral Suspension Compared with Reference Product in Healthy Adult Volunteers under Fed Conditions
CzechiaPF-07817883 Oral Tablet Bioavailability Study in Healthy Adults to Support Treatment of COVID‑19
BelgiumThe therapies tested most often in Infections and infestations trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
